Skip to main content
Menu

AlphaLISA SureFire Ultra Human Phospho-BCKDHA (Ser292) Detection Kit, 500 Assay Points

The AlphaLISA™ SureFire® Ultra™ Human Phospho-BCKDHA (Ser292) assay is a sandwich immunoassay for quantitative detection of phospho-BCKDHA (Ser292) in cellular lysates using Alpha Technology.

Feature Specification
Application Cell Signaling
Protocol Time 2h at RT
Sample Volume 10 µL

The AlphaLISA™ SureFire® Ultra™ Human Phospho-BCKDHA (Ser292) assay is a sandwich immunoassay for quantitative detection of phospho-BCKDHA (Ser292) in cellular lysates using Alpha Technology.

Product variants
Unit Size: 100 Assay Points
Part #:
ALSU-PBCKD-A-HV
List price
USD 722.00
Your online price:
Unit Size: 500 Assay Points
Part #:
ALSU-PBCKD-A500
List price
USD 2,441.00
Your online price:
Unit Size: 10,000 Assay Points
Part #:
ALSU-PBCKD-A10K
List price
USD 14,688.00
Your online price:
Unit Size: 50,000 Assay Points
Part #:
ALSU-PBCKD-A50K
List price
USD 46,690.00
Your online price:
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Overview

Branched-Chain Ketoacid Dehydrogenase E1-Alpha (BCKDHA) is the catalytic subunit of the BCKDC complex, which catalyzes the irreversible decarboxylation of branched-chain ketoacids derived from leucine, isoleucine, and valine. BCKDHA represents the rate-limiting step in branched-chain amino acid catabolism and is predominantly expressed in liver, muscle, kidney, and brain. Mutations in BCKDHA cause maple syrup urine disease (MSUD), characterized by accumulation of toxic ketoacid derivatives leading to neurological damage. MSUD severity varies depending on residual enzyme activity, ranging from classic severe forms to intermediate variants. Altered BCKDHA expression has been implicated in cancer metabolism, diabetes, and cardiovascular disease.

The AlphaLISA SureFire Ultra Human Phospho-BCKDHA (Ser292) is a sandwich immunoassay for the quantitative detection of phospho-BCKDHA (Ser292) in cellular lysates, using Alpha Technology.

Formats:

  • The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
  • The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
  • The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
  • The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.

AlphaLISA SureFire Ultra kits are compatible with:

  • Cell and tissue lysates
  • Antibody modulators
  • Biotherapeutic antibodies

AlphaLISA SureFire Ultra kits can be used for:

  • Cellular kinase assays
  • Receptor activation studies
  • High-throughput screening for preclinical studies

How it works

Phospho-AlphaLISA SureFire Ultra assay principle

The Phospho-AlphaLISA SureFire Ultra assay measures a protein target when phosphorylated at a specific residue.

The assay uses two antibodies which recognize the phospho epitope and a distal epitope on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of phosphorylated protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of phosphoprotein present in the sample.

assay principle Phospho AlphaLISA Surefire Ultra

 

Phospho-AlphaLISA SureFire Ultra two-plate assay protocol

The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Phospho-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.

2 plates assay protocol alphalisa surefire ultra phospho assay

Phospho-AlphaLISA SureFire Ultra one-plate assay protocol

Detection of Phosphorylated target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.

1 plate assay protocol alphalisa surefire ultra phospho assay

Assay validation

Inhibition of BCKDHA Phospho (Ser292) in HeLa cells

HeLa cells were seeded in a 96-well plate (40,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of BT2 for 8 hours.

After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). Phospho (Ser292), Total BCKDHA and Cofilin Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

As expected, treatment with BT2 resulted in a dose-dependent decrease in Phospho (Ser292) BCKDHA levels and a modest decrease in Total BCKDHA levels. Cofilin Total levels were unchanged (data not shown).

Validation of BCKDHA Phospho (Ser292) assay - inhibitor

Assay specificity/selectivity

Knockout validation of BCKDHA Phospho (Ser292) assay

BCKDHA Phospho (Ser292) levels were assessed in HEK293T cells (WT) and BCKDHA KO (Abcam, ab266439) cell lines cultured to confluence in T175 flasks at 37°C, 5% CO2.

Each flask was lysed in Lysis Buffer for 10 minutes at RT with shaking and BCKDHA Phospho (Ser292) levels were evaluated by AlphaLISA SureFire Ultra. For the detection step, 10 µL of cell lysate (10,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

BCKDHA Phospho (Ser292) was detected in WT but not KO cells. This confirms the specificity of the assay for the detection of BCKDHA protein.

Specificity validation of BCKDHA Phospho assay

Assay sensitivity

BCKDHA assay sensitivity - cell lysate dilution

Cell lysate was prepared from HeLa cells cultured to confluence in a T175 flask and lysed in 4 mL of Lysis Buffer.

Lysate was serially diluted in Lysis Buffer and BCKDHA Phospho (Ser292) and Total levels were evaluated by AlphaLISA SureFire Ultra. For the detection step, 10 µL of cell lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.

Approximate number of cells is indicated. The dotted line represents assay background. The BCKDHA assay has a broad dynamic range and can detect Phospho (Ser292) BCKDHA in less than 250 cells/datapoint.

 Phospho BCKDHA assay sensitivity

Specifications

Application
Cell Signaling
Automation Compatible
Yes
Brand
AlphaLISA SureFire Ultra
Detection Modality
Alpha
Product Group
Kit
Protocol Time
2h at RT
Sample Volume
10 µL
Shipping Conditions
Shipped in Blue Ice
Target
BCKDHA
Target Class
Phosphoproteins
Target Species
Human
Technology
Alpha
Therapeutic Area
Metabolic
Neuroscience
Oncology
Unit Size
500 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

1-3 of 3 Resources
Brochure Icon
Brochure
Alpha assays and reagents catalog

Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...

Brochure Icon
Brochure
Alpha SureFire Ultra no-wash immunoassay catalog

Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...

Brochure Icon
Brochure
Species compatibility for HTRF, AlphaLISA SureFire Ultra and Alpha SureFire Ultra Multiplex assays

This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...

Loading...

Scroll Icon

Revvity AI Assistant Beta